Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

However, Karp's exuberance about Palantir's Q3 results is warranted. The company blew past the consensus Wall Street revenue estimate of $1.09 billion. Its revenue growth accelerated from a 48% year ...

Enterprises in Brazil are accelerating digital transformation by incorporating generative AI (GenAI) into their processes, aided by tools from AWS and its ecosystem partners, according to a new ...

By Ebele Orakpo While some believe that Genetic Modification is the best way to achieve food sufficiency, others call it agro-terrorism/bioterrorism; Russia’s President Vladimir Putin was quoted as ...

ASCO discussant Krina Patel, MD, of the University of Texas MD Anderson Cancer Center in Houston, noted, "Ciltacabtagene ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial results and ...

In this free webinar, learn how to optimize timelines and expedite the market readiness of therapeutic proteins using acceleration levers. Attendees will ...

The resulting 124 I-evuzamitide (previously known as AT-01) has been shown to detect amyloidosis in organs like the heart, ...

Latin America faces a productivity crisis as industry declines and exports revert to raw materials, according to new ECLAC ...

Explore the definition, criteria, advantages, and list of India's Institutes of Eminence. Learn why these historical ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.